Who owns Synta Pharmaceuticals?

Key details on Synta Pharmaceuticals (Ticker: SNTA)

Who owns Synta Pharmaceuticals?

Is SNTA a good stock to own? Find out who bought Synta Pharmaceuticals, who sold Synta Pharmaceuticals (SNTA) stock, and who holds a large position in Synta Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
CAXTON 28.64M $150.08M Dec. 31, 2013
FMR 3.99M $20.92M Dec. 31, 2013
Jennison Associates 3.96M $20.75M Dec. 31, 2013
Perceptive Advisors 2.38M $15.03M Sept. 30, 2013
BlackRock Fund Advisors 2.29M $12.02M Dec. 31, 2013
S.A.C. Capital Advisors 2.01M $12.66M Sept. 30, 2013
JPMORGAN CHASE & CO 1.76M $9.22M Dec. 31, 2013
QVT Financial 1.75M $11.04M Sept. 30, 2013
Sectoral Asset Management 1.48M $11.30M Sept. 30, 2012
Vanguard 1.43M $7.48M Dec. 31, 2013
SUSQUEHANNA INTERNATIONAL 1.17M $6.15M Dec. 31, 2013
Ayer Capital Management 851635 $3.70M March 31, 2012
Manatuck Hill Partners 784116 $6.74M March 31, 2013
NORTHERN TRUST 726925 $3.81M Dec. 31, 2013
Driehaus Capital Management 713498 $6.14M March 31, 2013
Deutsche Bank Aktiengesellschaft 652298 $3.42M Dec. 31, 2013
STATE STREET CORPORATION 613001 $3.21M Dec. 31, 2013
Oxford Asset Management 601896 $3.80M Sept. 30, 2013
BlackRock Institutional Trust Company, N.A. 597924 $3.13M Dec. 31, 2013
Scoggin 559000 $4.81M March 31, 2013
Balyasny Asset Management 541120 $4.88M Dec. 31, 2012
Baker Bros. Advisors 500000 $2.62M Dec. 31, 2013
Hambrecht & Quist Capital Management 489750 $3.09M Sept. 30, 2013
Barclays 450521 $2.26M Dec. 31, 2013
Hanna Zanoni 435200 $2.75M Sept. 30, 2013
Jefferies 421200 $2.30M June 30, 2012
Ridgeback Capital Investments 411306 $2.25M June 30, 2012
Taylor Investment Counselors 403403 $2.11M Dec. 31, 2013
GOLDMAN SACHS 353389 $1.77M June 30, 2013
Catalyst Capital Advisors 341201 $1.79M Dec. 31, 2013
T. Rowe Price Associates 323000 $2.78M March 31, 2013
Jane Street Holding 282303 $1.41M June 30, 2013
Technical Financial Services 266465 $1.46M June 30, 2012
TIAA-CREF Investment Management 252095 $2.17M March 31, 2013
Sabby Management 250952 $1580 Sept. 30, 2013
D. E. Shaw & Co 240721 $1.26M Dec. 31, 2013
Geode Capital Management 205120 $1.29M Sept. 30, 2013
PointState Capital 200000 $1.80M Dec. 31, 2012
First Eagle Investment Management 200000 $870000 March 31, 2012
Credit Suisse AG 183997 $1.23M Dec. 31, 2013

Who sold Synta Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
RA Capital Management Sept. 30, 2011 465284 $1.51M
Redmile Sept. 30, 2011 274841 $893233
Millennium Management June 30, 2011 400301 $2.01M
Maverick Capital March 31, 2007 400000 $3.23M